Laser phototherapy following HpD administration in superficial neoplastic lesions.
We report our preliminary clinical experience with hematoporphyrin derivative (HpD) injection and argon or dye laser irradiation for the treatment of 61 surface neoplastic lesions in 7 patients. Forty-three sites were multiple basal cell carcinoma in 5 patients, and the remaining 18 were cutaneous and subcutaneous recurrent breast carcinoma after mastectomy in the thoracic wall. The patients were selected on the basis of the lack of indication for conventional therapeutic modalities. The selection of irradiation procedures and laser source was based on the thickness of the lesion and extension of the disease. The photochemical reaction between HpD injected i.v. at a dose of 3 mg/kg body weight and the laser beam at a dose of 60 to 120 J/cm2 resulted in 75% favorable responses at the treated sites. Optimal therapeutic effects appeared to be critically dependent on total light dose and tumor infiltration patterns. The phototherapeutic technique proved to be effective in selected cases of neoplastic lesions, especially when conventional treatment modalities were poorly indicated or contraindicated.
D000368:Aged; D001943:Breast Neoplasms / Q000532:radiotherapy*; D002280:Basal Cell Carcinoma / Q000532:radiotherapy*; D005260:Female; D006415:Hematoporphyrins / Q000627:therapeutic use; D006801:Humans; D007834:Lasers; D008297:Male; D008875:Middle Aged; D010778:Photochemotherapy; D012878:Skin Neoplasms / Q000532:radiotherapy*
D006415:Hematoporphyrins